TALEN

TALEN1-f2

ID

ZDB-TALEN-200818-1

Name

TALEN1-f2

Previous Names

None

Target

f2 (1)

Target Sequence 1

5' - TTTAATGTGACACAGCTG - 3'

Target Sequence 2

5' - TATCTGGGTTCCTGCAGA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
mi4008	f2

Expression

Gene expression in Wild Types + TALEN1-f2

No data available

Phenotype

Phenotype resulting from TALEN1-f2

No data available

Phenotype of all Fish created by or utilizing TALEN1-f2

Phenotype	Fish	Conditions	Figures
brain hemorrhagic, abnormal	f2^{mi4008/mi4008} (AB/TL)	standard conditions	Figure 5 from Grzegorski et al., 2020
posterior cardinal vein blood coagulation, fibrin clot formation delayed, abnormal	f2^{mi4008/mi4008} (AB/TL)	light damage: posterior cardinal vein, chemical treatment by environment: 6-aminohexanoic acid	Figure 6 from Grzegorski et al., 2020
whole organism hemorrhagic, abnormal	f2^{mi4008/mi4008} (AB/TL)	standard conditions	Figure 5 from Grzegorski et al., 2020
whole organism f2 expression decreased amount, abnormal	f2^{mi4008/mi4008} (AB/TL)	standard conditions	Figure 3 from Grzegorski et al., 2020
posterior cardinal vein blood coagulation, fibrin clot formation delayed, abnormal	f2^{mi4008/mi4008} (AB/TL)	light damage: posterior cardinal vein	Figure 6 from Grzegorski et al., 2020
whole organism decreased life span, abnormal	f2^{mi4008/mi4008} (AB/TL)	standard conditions	Figure 5 from Grzegorski et al., 2020
blood coagulation process quality, abnormal	f2^{mi4008/mi4008} (AB/TL)	light damage: posterior cardinal vein	Figure 6 from Grzegorski et al., 2020
liver f2 expression decreased amount, abnormal	f2^{mi4008/mi4008} (AB/TL)	standard conditions	Figure 3 from Grzegorski et al., 2020
blood coagulation process quality, abnormal	f2^{mi4008/mi4008} (AB/TL)	light damage: posterior cardinal vein, chemical treatment by environment: 6-aminohexanoic acid	Figure 6 from Grzegorski et al., 2020
blood coagulation process quality, abnormal	f2^{mi4008/mi4008}; la2Tg (AB/TL)	light damage: dorsal aorta	Figure 6 from Grzegorski et al., 2020
dorsal aorta blood coagulation, fibrin clot formation delayed, abnormal	f2^{mi4008/mi4008}; la2Tg (AB/TL)	light damage: dorsal aorta	Figure 6 from Grzegorski et al., 2020

Citations